Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Reccan AB logo — A breakthrough in the detection of pancreatic cancer

Reccan AB

A breakthrough in the detection of pancreatic cancer

Founded 2014 Sweden Sweden 3 employees Venture round Health Care

General Information

Company Name Reccan AB
Founded Year 2014
Location Sweden Sweden
Employees 3
Industries Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Reccan AB. To contact Reccan AB, visit reccandiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Reccan AB compare?

A PDF of Reccan AB and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Reccan AB soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Reccan AB

Reccan AB, a health tech startup founded in 2014 in Sweden, has been making waves in the medical industry with its breakthrough in the detection of pancreatic cancer. With the slogan "A breakthrough in the detection of pancreatic cancer," the company aims to improve the prognosis for patients diagnosed with this deadly disease. Reccan is dedicated to pioneering early diagnosis, believing it is the key to a better prognosis for pancreatic cancer patients. The company's vision is clear: setting a standard for early detection of pancreatic cancer to save lives. By finding the cancer at an earlier stage than currently possible, Reccan is working towards changing the trajectory of pancreatic cancer mortality. Early detection not only provides a better chance for effective interventions but also enhances the effectiveness of treatments. The most recent milestone for Reccan occurred with its Venture Round investment on 08 September 2020, with LU Innovation as the primary investor. This marks a significant step for the company as it strives to bring its vision to fruition and make a tangible impact in the realm of medical technology. With a promising outlook and a clear focus on addressing a critical health issue, Reccan AB is a company to watch in the coming years.

Business keywords: medtech, pancreatic cancer, early detection, prognosis improvement, diagnostic technology, solid cancer, tumor-specific treatment, cancer mortality, medical innovation, oncology, patient prognosis, early intervention, medical advancements

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
LU Innovation
08 Sep 2020

Reccan AB Alternatives & Competitors

View All Alternatives
Reccan AB vs
Blaze Bioscience
Blaze Bioscience United States

Dedicated to improving the lives of cancer patients

Venture round
25 employees
Biotechnology, Health Care
Reccan AB vs
Koning Health
Koning Health United States

Revolutionizing the breast imaging industry

Equity Crowdfunding
30 employees
Analytics, Health Care
Reccan AB vs
Craif Inc.
Craif Inc. United States

Harnessing the power of urinary miRNA to detect cancer early

Non Equity Assistance
19 employees
AI, Health Care
View all alternatives

FAQ About Reccan AB

A breakthrough in the detection of pancreatic cancer
Reccan AB was founded in 2014.
Reccan AB is headquartered in Sweden.
Reccan AB operates in Health Care. Its work centres on medtech, pancreatic cancer, early detection and prognosis improvement.
Reccan AB has approximately 3 employees.
Reccan AB has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Reccan AB include Blaze Bioscience, Koning Health, Craif Inc., Proteocyte AI, Optellum. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Reccan AB and Blaze Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Reccan AB, https://bouncewatch.com/company/reccan-ab, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout